2013 ACC/AHA Guideline: A guideline for the population - Without evidence from the population

Merle Myerson; Robert S. Rosenson

doi:10.1007/s10557-014-6513-1

2013 ACC/AHA Guideline: A guideline for the population - Without evidence from the population

Merle Myerson
, Robert S. Rosenson

Research output: Contribution to journal › Editorial

5 Scopus citations

Original language	English
Pages (from-to)	203-204
Number of pages	2
Journal	Cardiovascular Drugs and Therapy
Volume	28
Issue number	3
DOIs	https://doi.org/10.1007/s10557-014-6513-1
State	Published - Jun 2014

Access to Document

10.1007/s10557-014-6513-1

Cite this

@article{e18b1476fa0e411e9d91bcb2b4c82fcd,

title = "2013 ACC/AHA Guideline: A guideline for the population - Without evidence from the population",

author = "Merle Myerson and Rosenson, \{Robert S.\}",

note = "Funding Information: There is no shortage of high-quality cardiovascular epidemiological studies with many sponsored by the National Institutes of Health. The Framingham Heart Study, began enrolling participants in 1948 and reported results in 1961 that established the concept of “risk factors” for cardiovascular disease [4].",

year = "2014",

month = jun,

doi = "10.1007/s10557-014-6513-1",

language = "English",

volume = "28",

pages = "203--204",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Springer",

number = "3",

}

TY - JOUR

T1 - 2013 ACC/AHA Guideline

T2 - A guideline for the population - Without evidence from the population

AU - Myerson, Merle

AU - Rosenson, Robert S.

N1 - Funding Information: There is no shortage of high-quality cardiovascular epidemiological studies with many sponsored by the National Institutes of Health. The Framingham Heart Study, began enrolling participants in 1948 and reported results in 1961 that established the concept of “risk factors” for cardiovascular disease [4].

PY - 2014/6

Y1 - 2014/6

UR - https://www.scopus.com/pages/publications/84903757393

U2 - 10.1007/s10557-014-6513-1

DO - 10.1007/s10557-014-6513-1

M3 - Editorial

C2 - 24610170

AN - SCOPUS:84903757393

SN - 0920-3206

VL - 28

SP - 203

EP - 204

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

IS - 3

ER -